DIATOR-Diabetes Intervention With Atorvastatin

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
Clinical studies have shown that immunomodulators (like Anti-CD3 antibodies) have effects on beta-cell-preservation. The lipid-lowering agent atorvastatin is also a potent immunomodulator. In this study the effects of 80 mg atorvastatin per day on preservation of beta-cell function in recent onset type 1 diabetes were studied, as determined by stimulated C-peptide levels.
Epistemonikos ID: 80f8fe8eaa696383c034e1d1dcca361423881132
First added on: May 05, 2024